Timlo.net--Life of the world community may not return to normal until a drug is found that can treat the corona virus. Even better, if there is a vaccine that can prevent people from becoming infected with the corona virus.
Fortunately there is good news. The COVID-19 vaccine made by the University of Oxford, England is able to trigger an immune response in young and old patients. This was revealed by the pharmaceutical company AstraZeneca Plc which also helps produce the vaccine. The company claims that the vaccine produces low side effects in elderly patients (elderly). This, of course, is good news because older patients generally have a weaker immune system than younger patients. So the elderly are considered a group that is prone to being infected with the corona virus, wrote Ubergizmo, Monday (26/10).
“It is encouraging to see similar immunogenicity responses in older patients and young adults and low reactogenicity in older patients where the severity of COVID-19 disease is higher. These results further establish a body of evidence for the safety and immunogenicity of AZD1222, ”said a company spokesman.
But this vaccine is not ready for use by the general public. The vaccines they are developing still need permission from government agencies. British Health Secretary Matt Hancock believes the vaccine will be ready for release in the first half of 2021.
Editor: Ranu Ario
–
